BackgroundAdolescents and young adults (AYA) with opioid use disorder (OUD) remain less likely than adults to receive medications for opioid use disorder (MOUD), despite clinical guidance supporting pharmacotherapy and evidence that early medication treatment improves engagement. Primary care may offer a developmentally appropriate setting for AYA MOUD delivery; however, limited evidence describes the workflows required to support movement from first contact to medication initiation and follow-up.MethodsWe conducted a multi-site qualitative implementation study with clinicians and staff involved in AYA MOUD delivery across four primary care-based programs in Greater Boston. Between July and November 2025, the first author conducted semi-structured Zoom interviews with 12 participants: physicians (n = 6), nurse practitioners (n = 3), one registered nurse/care manager, one patient navigator, and one administrator. Interviews examined referral pathways, treatment initiation, medication access, staffing, behavioral health linkage, and perceived barriers and facilitators. CFIR informed development of the interview guide and initial code structure. Codes were applied with attention to site-specific workflows and implementation practices, followed by hybrid deductive-inductive thematic analysis to identify pathway-centered themes.ResultsParticipants described AYA MOUD delivery as a sequence of time-sensitive operational steps--including outreach, scheduling, confidentiality communication, prescription routing, pharmacy coordination, fill confirmation, and early follow-up--rather than a discrete prescribing event. Four themes characterized how clinics supported initiation and early engagement for a population with unique developmental needs. First, rapid, low-barrier entry supported conversion of referrals into treatment initiation through same- or next-day outreach, flexible first-touch options, and clear confidentiality communication. Second, compact interdisciplinary teams sustained engagement by assigning ownership for outreach, missed visits, refills, family communication, and follow-up. Third, medication access depended on infrastructure that fit routine clinic work, including prior authorization ownership, pharmacy communication, order sets, and tracking prescription completion. Fourth, harm reduction services and behavioral health bridge care supported continuity during instability or delayed specialty care access. Across sites, implementation varied in staffing, co-location, electronic health record capacity, and pharmacy partnerships, and participants emphasized visible task ownership and reliable handoffs.ConclusionsAYA MOUD implementation in primary care requires more than prescriber availability. Clinics must organize treatment as coordinated, developmentally responsive, and measurable work, with explicit ownership for rapid entry, medication access, early follow-up, and bridge support. Findings identify implementation targets for future evaluation, including time to first contact, time to first dose, medication fill completion, early follow-up, and retention in care.